中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2009年
4期
355-358
,共4页
戚基萍%刘微%张淑君%昝丽坤%孙玉兰%宋月佳
慼基萍%劉微%張淑君%昝麗坤%孫玉蘭%宋月佳
척기평%류미%장숙군%잠려곤%손옥란%송월가
苦参碱%神经胶质瘤%Fas%细胞凋亡
苦參堿%神經膠質瘤%Fas%細胞凋亡
고삼감%신경효질류%Fas%세포조망
Martrine%Glioma%Fas%Apoptosis
目的 探讨苦参碱应用前后C6脑胶质瘤大鼠模型中Fas因子的表达变化及意义.方法采用脑立体定向技术,将体外培养的C6胶质瘤细胞注入大鼠尾状核区制备胶质瘤大鼠模型,并根据是否用药及用药量的多少分为空白对照组、冰片组、苦参碱低剂量组、苦参碱高剂量组、苦参碱低剂量+冰片组、苦参碱高剂量+冰片组.通过大鼠生存状态、标本的大体所见、MRI、HE染色观察苦参碱对胶质瘤大鼠模型生存质量及胶质瘤体积的影响,用免疫组织化学方法检测苦参碱对胶质瘤大鼠模型肿瘤细胞中Fas表达的影响.结果 大鼠生存状态、标本的大体所见、MRI及HE染色显示苦参碱可显著提高胶质瘤大鼠模型的生存质量,抑制胶质瘤细胞增殖.免疫组化结果显示,苦参碱低剂量+冰片组(98.16±11.82)、苦参碱高剂量+冰片组(1 12.80±12.12)Fas表达高于空白对照组(39.09±7.79)、冰片组(46.87±7.43)、苦参碱低剂量组(42.41±7.83)、苦参碱高剂量组(44.20±7.47),苦参碱高剂量+冰片组Fas表达高于苦参碱低剂量+冰片组,差异均有统计学意义(P<0.05).结论 苦参碱能增加胶质瘤细胞中Fas的表达,抑制胶质瘤细胞增殖.
目的 探討苦參堿應用前後C6腦膠質瘤大鼠模型中Fas因子的錶達變化及意義.方法採用腦立體定嚮技術,將體外培養的C6膠質瘤細胞註入大鼠尾狀覈區製備膠質瘤大鼠模型,併根據是否用藥及用藥量的多少分為空白對照組、冰片組、苦參堿低劑量組、苦參堿高劑量組、苦參堿低劑量+冰片組、苦參堿高劑量+冰片組.通過大鼠生存狀態、標本的大體所見、MRI、HE染色觀察苦參堿對膠質瘤大鼠模型生存質量及膠質瘤體積的影響,用免疫組織化學方法檢測苦參堿對膠質瘤大鼠模型腫瘤細胞中Fas錶達的影響.結果 大鼠生存狀態、標本的大體所見、MRI及HE染色顯示苦參堿可顯著提高膠質瘤大鼠模型的生存質量,抑製膠質瘤細胞增殖.免疫組化結果顯示,苦參堿低劑量+冰片組(98.16±11.82)、苦參堿高劑量+冰片組(1 12.80±12.12)Fas錶達高于空白對照組(39.09±7.79)、冰片組(46.87±7.43)、苦參堿低劑量組(42.41±7.83)、苦參堿高劑量組(44.20±7.47),苦參堿高劑量+冰片組Fas錶達高于苦參堿低劑量+冰片組,差異均有統計學意義(P<0.05).結論 苦參堿能增加膠質瘤細胞中Fas的錶達,抑製膠質瘤細胞增殖.
목적 탐토고삼감응용전후C6뇌효질류대서모형중Fas인자적표체변화급의의.방법채용뇌입체정향기술,장체외배양적C6효질류세포주입대서미상핵구제비효질류대서모형,병근거시부용약급용약량적다소분위공백대조조、빙편조、고삼감저제량조、고삼감고제량조、고삼감저제량+빙편조、고삼감고제량+빙편조.통과대서생존상태、표본적대체소견、MRI、HE염색관찰고삼감대효질류대서모형생존질량급효질류체적적영향,용면역조직화학방법검측고삼감대효질류대서모형종류세포중Fas표체적영향.결과 대서생존상태、표본적대체소견、MRI급HE염색현시고삼감가현저제고효질류대서모형적생존질량,억제효질류세포증식.면역조화결과현시,고삼감저제량+빙편조(98.16±11.82)、고삼감고제량+빙편조(1 12.80±12.12)Fas표체고우공백대조조(39.09±7.79)、빙편조(46.87±7.43)、고삼감저제량조(42.41±7.83)、고삼감고제량조(44.20±7.47),고삼감고제량+빙편조Fas표체고우고삼감저제량+빙편조,차이균유통계학의의(P<0.05).결론 고삼감능증가효질류세포중Fas적표체,억제효질류세포증식.
Objective To investigate the effect of matrine on Fas expression in C6 glima in a tumor-bearing rat model. Methods Cultured cerebral glioma C6 cells wgre injected stereotactically into the lef tcaudate nucleus of the rats.The ratswere randomized into untreated group,bomeol-treated group,low-dose matrine group,high-dose maaine group,low-dose matrine+bomeol group,and high-dose matrine+borneol group.The effect of matrine on the quality of life of the rats and the glioma volume was evaluated according to the survival state of the rats and by gross observation,magnetic resonance imaging(MRJ)and HE smining of the brain tissue.Immunohistochemistry was performed to detect Fas expression in the glioma cells. Results The survival state ofthe rats,gross observation of the brain specimen. and results of MRI and HE staining all showed that matrine significantly improved the quality oflife of the glioma-bearing rats and inhibited the glioma cell proliferation.Fas expression Was significantly higher in low-dose matrine+bomeol group(98.16±11.82) and high-dose matrine+bomeol group(112.80±12.12)than in untreated group(39.09±7.79),bomeol group(46.87±7.43),low-dose matrinc group(42.41±7.83),and high-dose matrine group(44.20±7.47)(P<0.05).Fas expression Was obviously upregulated in the high-dose matrine+bomeol group aS compared with the low-dose matrine+bomeol group(P<0.05).Conclusion Matrine Can significantly upregulate Fas expression in glioma and inhibit glioma cell proliferation in the glioma-bearing rat model.